Synonyms: OBE101 [2] | SERC® | Vasomotal®
betahistine is an approved drug (FDA (1970s))
Compound class:
Synthetic organic
Comment: This is an orally delivered histamine receptor modulator that has weak agonist activity at histamine H1 receptors and more potent antagonist activity at the H3 receptor subtype [1].
|
|
References |
1. Fossati A, Barone D, Benvenuti C. (2001)
Binding affinity profile of betahistine and its metabolites for central histamine receptors of rodents. Pharmacol Res, 43 (4): 389-92. [PMID:11352543] |
2. Pierson PD, Fettes A, Freichel C, Gatti-McArthur S, Hertel C, Huwyler J, Mohr P, Nakagawa T, Nettekoven M, Plancher JM et al.. (2009)
5-hydroxyindole-2-carboxylic acid amides: novel histamine-3 receptor inverse agonists for the treatment of obesity. J Med Chem, 52 (13): 3855-68. [PMID:19456097] |